Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ACTRN12625000524493) titled 'Shortening the Treatment Duration for Vivax Malaria: A Study Comparing 7-day and 14-day Primaquine Therapy' on May 26.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Parallel
Primary Sponsor: Hayatabad Medical Complex, Peshawar
Condition:
Malaria
Malaria
Infection - Other infectious diseases
Intervention:
Participants in the intervention group will receive a 7-day regimen of primaquine at a dose of 1 mg/kg/day, administered orally. Drug adherence will be ensured through direct observation of therapy (DOT) during ho...